PregnanTech

📍 Misgav, Israel🗓 Founded 2018👥 9 employees💰 Last funded Oct 2025
Medical Device🌐 pregnantech.com
Website LinkedIn
Developing a game changing device for the delaying of preterm birth, which is the most common pregnancy complication (1 in 10 women worldwide), and the leading cause of child morbidity and mortality until the age of 5. PregnanTech has developed LIONESS, a novel, non-surgical solution for delaying preterm birth. Inserted in a 3-5 minute out-patient procedure, the LIONESSs unique structure allows it to stay stable in place throughout the entire pregnancy, with a self-release mechanism in case of active labor. ​ LIONESS was successfully tested in a range of preclinical studies, and a first in women (FIH) clinical safety trial is currently in progress. Findings are reassuring and attest to the vast potential of the device. We are planning on conducting a multi-center pivotal trial next year, and are actively looking for medical institutions worldwide to help us conduct it. If you are a part of a medical institution and are interested in taking an active part in revolutionizing the future of obstetrics with PregnanTech, do not hesitate to reach out!
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Israel
1
Frequently asked questions
Who invested in PregnanTech?
PregnanTech has 1 investors on record on gritt.io and 1 late-stage investors.
When did PregnanTech last raise funding?
The most recent investment in PregnanTech recorded on gritt.io was in October 2025.
When was PregnanTech founded?
PregnanTech was founded in 2018.
What industry is PregnanTech in?
PregnanTech operates in Medical Device. Find similar Medical Device investors on gritt.io.
Where is PregnanTech based?
PregnanTech is headquartered in Misgav, Israel.